REFERENCES
- Van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol. 1981;26:84–96.
- Nakamura Y, Sotozono C, Kinoshita S. Inflammatory cytokines in normal human tears. Curr Eye Res. 1998;17:673–676.
- Haynes RJ, Tighe PJ, Dua HS. Antimicrobial defensin peptides of the human ocular surface. Br J Ophthalmol. 1999;83:737–741.
- Fluckinger M, Haas H, Merschak P, Glasgow BJ, Redl B. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother. 2004;48:3367–3372.
- The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf. 2007;5:75–92.
- Navone R, Lunardi C, Gerli R, et al. Identification of tear lipocalin as a novel autoantigen target in Sjögren’s syndrome. J Autoimmun. 2005;25:229–234.
- Wray W, Boulikas T, Wray VP, Hancock R. Silver staining of proteins in polyacrylamide gels. Anal Biochem. 1981;118:197–203.
- Stuchell RN, Feldman JJ, Farris RL, Mandel ID. The effect of collection technique on tear composition. Invest Ophthalmol Vis Sci. 1984;25:374–377.
- Grus FH, Dick B, Augustin AJ, Pfeiffer N. Analysis of the antibody repertoire in tears of dry-eye patients. Ophthalmologica. 2001;215:430–434.
- Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Interaction of tear lipocalin with lysozyme and lactoferrin. Biochem Biophys Res Commun. 1999;265:322–325.
- Gouveia SM, Tiffany JM. Human tear viscosity: An interactive role for proteins and lipids. Biochim Biophys Acta. 2005;1753:155–163.
- Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7:812–818.
- Vaz NM, de Faria AMC, Verdolin BA, Silva Neto AF, Menezes JS, Carvalho CR. The conservative physiology of the immune system. Braz J Med Biol Res. 2003;36:13–22.